Sildenafil protects epithelial cell through the inhibition of xanthine oxidase and the impairment of ROS production

References

• Bray RC. In:Boyer PD The enzyme. 3rd ed.New York:Academic Press;1975. Vol.XII, part B, 299–419.
   Google Scholar
• Futterman S. Enzymatic oxidation of vitamin A aldehyde to vitamin A acid. J Biol Chem 1962;237:677–680.
   PubMed Web of Science ®Google Scholar
• Olson JA. The metabolism of vitamin A. Pharmacol Rev 1967;19:559–596.
   PubMed Web of Science ®Google Scholar
• Lee MO, Manthey CL, Sladek NE. Identification of mouse liver aldehyde dehydrogenases that catalyze the oxidation of retinaldehyde to retinoic acid. Biochem Pharmacol 1991;42:1279–1285.
   PubMed Web of Science ®Google Scholar
• Taibi G, Paganini A, Gueli MC, Ampola A, Nicotra CMA. Xanthine oxidase catalyzes the synthesis of retinoic acid. J Enz Inhib 2001;16:275–285.
   Google Scholar
• Enroth C, Eger BT, Okamoto K, Nishino T, Nishino T, Pai EF. Crystal structure of bovine milk xanthine dehydroge-nase and xanthine oxidase: structure-based mechanism of conversion. Proc Natl Acad Sci USA 2000;97:10723–10728.
   PubMed Web of Science ®Google Scholar
• McManaman JL, Bain DL. Structural and conformational analysis of the oxidase to dehydrogenase conversion of xanthine oxidoreductase. J Biol Chem 2002;277:21261–21268.
   PubMed Web of Science ®Google Scholar
• Hille R, Nishino T. Xanthine oxidase and xanthine dehydrogenase. FASEB J 1995;9:995–1003.
   PubMed Web of Science ®Google Scholar
• Rouquette M, Page S, Bryant R, Benboubetra M, Stevens CR, Blake DR. Xanthine oxidoreductase is asymmetrically localized on the outer surface of human endothelial and epithelial cells in culture. FEBS Lett 1998;426:397–401.
   PubMed Web of Science ®Google Scholar
• Granger DN, Rutili G, McCord JM. Role of superoxide infeline intestinal ischemia. Gastroenterology 1981;81:22–29.
   PubMed Web of Science ®Google Scholar
• McCord JM. Oxygen-derived free radicals in post-ischemic tissue injury. N Engl J Med 1985;312:159–163.
   PubMed Web of Science ®Google Scholar
• Meneshian A, Bulkley GB. The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction. Microcirculation 2002;9:161–175.
   PubMed Web of Science ®Google Scholar
• Godber BLJ, Doel JJ, Durgan J, Eisenthal R, Harrison R. A new route in peroxynitrite: a role of xanthine oxidoreductase. FEBS Lett 2000;475:93–96.
   PubMed Web of Science ®Google Scholar
• Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 2004;555:589–606.
   PubMed Web of Science ®Google Scholar
• Farquharson CAJ, Butler R, Hill A, Belch JJF, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002;106:221–226.
   PubMed Web of Science ®Google Scholar
• Siems WG, Grune T, Werner A, Gerber G, Buntrock P, Schneider W. Protective influence of oxypurinol on the trini-trobenzene sulfonic acid (TNB) model of inflammatory bowel disease in rats. Cell Mol Biol 1992;38:189–199.
   PubMed Web of Science ®Google Scholar
• Miesel R, Zuber M. Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatic diseases. Inflammation 1993;17:551–561.
   PubMed Web of Science ®Google Scholar
• Page S, Powell D, Benboubetra M, Clifford R, Stevens CR, Blake DR, Selase F, Wolstenholme AJ, Harrison R. Xanthine oxidoreductase in human mammary epithelial cells: activation in response to inflammatory cytokines. Biochim Biophys Acta 1998;1381:191–202.
   PubMed Web of Science ®Google Scholar
• Qu XW, Rozenfeld RA, Huang W, Bulkley GB, Hsueh W. Xanthine oxidase in platelet activating factor induced intestinal injury in the rat. Gut 1999;44:203–211.
   PubMedGoogle Scholar
• Day RO, Graham GG, Hicks M, McLachlan AJ, Stocker SL, Williams KM. Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol. Clin Pharmacokinet 2007;46:623–644.
   PubMed Web of Science ®Google Scholar
• Michelakis ED, Tymchak W, Lien D, Webster L, Hashimoto K, Archer SL. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 2002;105:2398–2403.
   PubMed Web of Science ®Google Scholar
• Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, Wang SH, Modry D, Archer SL. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 2003;108:2066–2069.
   PubMed Web of Science ®Google Scholar
• Sastry BK, Narasimhan C, Reddy NK, Raju BS. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo controlled, double blind, cross over study. J Am Coll Cardiol 2004;43:1149–1153.
   PubMed Web of Science ®Google Scholar
• Mikhail GW, Prasad SK, Li W, Rogers P, Chester AH, Bayne S, Stephens D, Khan M, Gibbs JS, Evans TW, Mitchell A, Yacoub MH, Gatzoulis MA. Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects. Eur Heart J 2004;25:431–436.
   PubMed Web of Science ®Google Scholar
• Gori T, Sicuro S, Dragoni S, Donati G, Forconi S, Parker JD. Sildenafil prevents endothelial dysfunction induced by ischemia and reperfusion via opening of adenosine triphosphate-sensitive potassium channels: a human in vivo study. Circulation 2005;111:742–746.
   PubMed Web of Science ®Google Scholar
• Medina P, Segarra G, Martínez-León JB, Vila JM, Otero E, Lluch S. Relaxation induced by cGMP phosphodiesterase inhibitors sildenafil and zaprinast in human vessels. Ann Thorac Surg 2000;70:1327–1331.
   PubMedGoogle Scholar
• Medina P, Segarra G, Martínez-León JB, Vila JM, Otero E, Lluch S. Relaxation and cGMP formation in response to sildenafil and sodium nitroprusside in saphenous veins from normotensive and hypertensive patients. Am J Hypertens 2002;15:798–802.
   PubMedGoogle Scholar
• Wallis RM, Corbin JD, Francis SH, Ellis P. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. Am J Cardiol 1999;83:3–12.
   PubMed Web of Science ®Google Scholar
• Cremers B, Scheler M, Maack C, Wendler O, Schäfers HJ, Südkamp M, Böhm M. Effects of sildenafil (Viagra) on human myocardial contractility, in vitro arrhythmias, and tension of internal mammaria arteries and saphenous veins. J. Cardiovas Pharmacol 2003;41:734–743.
   PubMedGoogle Scholar
• Taibi G, Carruba G, Cocciadiferro L, Granata OM, Nicotra CMA. Low levels of both xanthine dehydrogenase and cellular retinol binding protein are responsible for the retinoic acid deficiency in malignant human mammary epithelial cells. Steroid Enzymes and Cancer: Ann NY Acad Sci 2009;1155:268–272.
   PubMedGoogle Scholar
• Olson JS, Ballou DP, Palmer G, Massey V. The reaction of xanthine oxidase with molecular oxygen. J Biol Chem 1974;249:4350–4362.
   PubMed Web of Science ®Google Scholar
• Massey V, Brumby PE, Komai H, Palmer G. Studies on milk xanthine oxidase. Some spectral and kinetic properties. J Biol Chem 1969;244:1682–1691.
   PubMed Web of Science ®Google Scholar
• Kim JH, Hille R. Reductive half-reaction of xanthine oxidase with xanthine. Observation of a spectral intermediate attributable to the molybdenum center in the reaction of enzyme with xanthine. J Biol Chem 1993;268:44–51.
   PubMed Web of Science ®Google Scholar
• Avis PG, Bergel F, Bray RC. Cellular constituents. The chemistry of xanthine oxidase. Part III. Estimations of the co-factors and the catalytic activities of enzymes fractions from cow's milk. J Chem Soc 1956;1219–1226.
   Google Scholar
• Walker JM. Non denaturing polyacrylamide gel electrophoresis of proteins. In:Walker JM, The protein protocolos handbook. Humana Press; Totowa, New Jersey. 1996. 51–54.
   Google Scholar
• Manchenko G, Handbook of detection of enzyme on electrophoretic gels. CRC Press; Boca Raton, Florida 1994.
   Google Scholar
• Plumb JA. Cell sensitivity assays: the MTT assay. Methods Mol Med 2004;88:165–169.
   PubMedGoogle Scholar
• Segel IH, Enzyme kinetics. New York: Wiley Interscience; 1975.
   Google Scholar
• Mei DA, Gross GJ, Nithipatikom K. Simultaneous determination of adenosine, inosine, hypoxanthine, xanthine, and uric acid in microdialysis samples using microbore column high-performance liquid chromatography with a diode array detector. Anal Biochem 1996;238:34–39.
   PubMed Web of Science ®Google Scholar
• Keshavarzian A, Morgan G, Sedghi S, Gordon JH, Doria M. Role of reactive oxygen metabolites in experimental colitis. Gut 1990;31:786–790.
   PubMed Web of Science ®Google Scholar
• Ben-Hamida A, Man WK, McNeil N, Spencer J. Histamine, xanthine oxidase generated oxygen-derived free radicals and Helicobacter pylori in gastroduodenal inflammation and ulceration. Inflamm Res 1998;47:193–199.
   PubMedGoogle Scholar
• Reynolds MD. Gout and hyperuricemia associated with sickle-cell anemia. Semin Arthritis Rheum 1983;12:404–413.
   PubMedGoogle Scholar
• Osarogiagbon UR, Choong S, Belcher JD, Vercellotti GM, Paller MS, Hebbel RP. Reperfusion injury pathophysiology in sickle transgenic mice. Blood 2000;96:314–320.
   PubMed Web of Science ®Google Scholar
• Aslan M, Ryan TM, Adler B, Townes TM, Parks DA, Thompson JA, Tousson A, Gladwin MT, Patel RP, Tarpey MM, Batinic-Haberle I, White CR, Freeman BA. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci USA 2001;98:15215–15220.
   PubMed Web of Science ®Google Scholar
• Sertac A, Bingol F, Aydin S, Uslu A. Peroxidative damage in sickle-cell erythrocyte ghosts: protective effect of allopurinol. Gen Pharmacol 1997;28:427–428.
   PubMedGoogle Scholar
• Boyce EG, Umland EM. Sildenafil citrate: a therapeutic update. Clin Ther 2001;23:2–23.
   PubMed Web of Science ®Google Scholar
• Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HHHW, Harrison DG, Griendling KK. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med 2008;45:1340–1351.
   PubMed Web of Science ®Google Scholar
• Westover A, Harrison CB, Selemidis S. NOX2-containing NADPH oxidase and Xanthine oxidase are sources of superoxide in mouse trachea. Clin Exp Pharm Physiol 2009;36:331–333.
   PubMedGoogle Scholar
• Muzaffar S, Shukla N, Bond M, Sala-Newby GB, Newby AC, Angelini GD, Jeremy JY. Superoxide from NADPH oxidase upregulates type 5 phosphodiesterase in human vascular smooth muscle cells: inhibition with iloprost and NONOate. Br J Pharmacol 2008;155:847–856.
   PubMedGoogle Scholar